STING1 and neoplasm: In gastric cancer cell lines, for instance, metformin has demonstrated the ability to not only inhibit the mTOR1 signaling pathway via classical AMPK-dependent or independent mechanisms but also to exhibit anti-tumor effects by activating the cGAS-STING pathway [55].